Analysis of HIV-1 protease mutants to understand mechanisms of resistance

被引:0
|
作者
Liu, F
Boross, P
Tozser, J
Louis, JM
Harrison, RW
Weber, IT
机构
[1] Georgia State Univ, Dept Biol, Atlanta, GA USA
[2] Debrecen Univ, Fac Med, Dept Biochem & Mol Biol, Debrecen, Hungary
[3] NIDDKD, Phys Chem Lab, NIH, Bethesda, MD 20892 USA
[4] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:12 / 12
页数:1
相关论文
共 50 条
  • [31] HIV-1 Protease: Structural Perspectives on Drug Resistance
    Weber, Irene T.
    Agniswamy, Johnson
    VIRUSES-BASEL, 2009, 1 (03): : 1110 - 1136
  • [32] Molecular Basis for Drug Resistance in HIV-1 Protease
    Ali, Akbar
    Bandaranayake, Rajintha M.
    Cai, Yufeng
    King, Nancy M.
    Kolli, Madhavi
    Mittal, Seema
    Murzycki, Jennifer F.
    Nalam, Madhavi N. L.
    Nalivaika, Ellen A.
    Oezen, Ayseguel
    Prabu-Jeyabalan, Moses M.
    Thayer, Kelly
    Schiffer, Celia A.
    VIRUSES-BASEL, 2010, 2 (11): : 2509 - 2535
  • [33] Computational Prediction of HIV-1 Resistance to Protease Inhibitors
    Hosseini, Ali
    Alibes, Andreu
    Noguera-Julian, Marc
    Gil, Victor
    Paredes, Roger
    Soliva, Robert
    Orozco, Modesto
    Guallar, Victor
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2016, 56 (05) : 915 - 923
  • [34] The role of polymorphisms at position 89 in the HIV-1 protease gene in the development of drug resistance to HIV-1 protease inhibitors
    Martinez-Cajas, Jorge L.
    Wainberg, Mark A.
    Oliveira, Maureen
    Asahchop, Eugene L.
    Doualla-Bell, Florence
    Lisovsky, Irene
    Moisi, Daniela
    Mendelson, Ella
    Grossman, Zehava
    Brenner, Bluma G.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (04) : 988 - 994
  • [35] Drug resistance and substrate recognition in HIV-1 protease
    Prabu-Jeyabalan, MM
    King, NM
    Nalivaika, E
    Scott, WRP
    Schiffer, CA
    ANTIVIRAL THERAPY, 2002, 7 : S48 - S48
  • [36] Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease
    Rosin, CD
    Belew, RK
    Morris, GM
    Olson, AJ
    Goodsell, DS
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (04) : 1369 - 1374
  • [37] Bayesian network analysis of resistance pathways against HIV-1 protease inhibitors
    Deforche, K.
    Camacho, R.
    Grossman, Z.
    Silander, T.
    Soares, M. A.
    Moreau, Y.
    Shafer, R. W.
    Van Laethem, K.
    Carvalho, A. P.
    Wynhoven, B.
    Cane, P.
    Snoeck, J.
    Clarke, J.
    Sirivichayakul, S.
    Ariyoshi, K.
    Holguin, A.
    Rudich, H.
    Rodrigues, R.
    Bouzas, M. B.
    Cahn, P.
    Brigido, L. F.
    Soriano, V.
    Sugiura, W.
    Phanuphak, P.
    Morris, L.
    Weber, J.
    Pillay, D.
    Tanuri, A.
    Harrigan, P. R.
    Shapiro, J. M.
    Katzenstein, D. A.
    Kantor, R.
    Vandamme, A.-M.
    INFECTION GENETICS AND EVOLUTION, 2007, 7 (03) : 382 - 390
  • [38] HIV-1 protease double mutants analysis by NMA indicates convergence to flexibility of the wild type
    Braz, A. S. K.
    de Conto, V.
    Perahia, D.
    Scott, L. P. B.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2013, 42 : S174 - S174
  • [39] Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3
    Heaslet, H
    Kutilek, V
    Morris, GM
    Lin, YC
    Elder, JH
    Torbett, BE
    Stout, CD
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 356 (04) : 967 - 981
  • [40] Molecular dynamics simulations of HIV-1 protease suggest different mechanisms contributing to drug resistance
    Wartha, F
    Horn, AHC
    Meiselbach, H
    Sticht, H
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2005, 1 (02) : 315 - 324